Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).
about
Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Genetically‑modified stem cell ...... sed targeted therapy (Review).
@en
Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein
@nl
type
label
Genetically‑modified stem cell ...... sed targeted therapy (Review).
@en
Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein
@nl
prefLabel
Genetically‑modified stem cell ...... sed targeted therapy (Review).
@en
Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein
@nl
P2093
P2860
P921
P356
P1476
Genetically‑modified stem cell ...... sed targeted therapy (Review).
@en
P2093
Georgia Sotiropoulou
Ioannis Christodoulou
Maria Goulielmaki
Marina Devetzi
Nicolas Khoury
Vassilis Zoumpourlis
P2860
P304
P356
10.3892/IJMM.2018.3361
P577
2018-01-03T00:00:00Z
2018-03-01T00:00:00Z